JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 84 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $5,668,039 | -52.6% | 5,106,341 | 0.0% | 0.12% | -57.8% |
| Q3 2022 | $11,949,000 | -9.5% | 5,106,341 | +17.2% | 0.28% | -19.4% |
| Q2 2022 | $13,206,000 | -58.4% | 4,358,433 | -6.9% | 0.34% | -48.2% |
| Q1 2022 | $31,780,000 | +32.9% | 4,680,412 | +63.5% | 0.66% | +88.5% |
| Q4 2021 | $23,908,000 | +130.5% | 2,863,198 | +105.1% | 0.35% | +123.7% |
| Q3 2021 | $10,374,000 | – | 1,396,203 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
| TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
| COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
| Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
| Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
| PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
| RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
| Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
| Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |